Correlates of non-adherence to antiretroviral therapy in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam

International Journal of STD and AIDS

Volumn 25, Issue 9, 2014, Pages 662-668

  Jordan, M R ^a,b   Obeng Aduasare, Y ^a   Sheehan, H ^a   Hong, S Y ^a,b   Terrin, N ^b   Duong, D V ^c   Trung, N V ^c   Wanke, C ^a,b   Kinh, N V ^c   Tang, A M ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c National Hospital of Tropical Diseases   (Viet Nam)

Author keywords

adherence; AIDS; antiretroviral therapy; HIV; injection drug users; substance abuse; Vietnam

Indexed keywords

AMPHETAMINE DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CANNABIS; DIAMORPHINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTIRETROVIRUS AGENT;

ADULT; ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; ARTICLE; CANNABIS USE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; HARM REDUCTION; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIKERT SCALE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PRIORITY JOURNAL; PROSTITUTION; SMOKING; SUBSTANCE USE; TREATMENT DURATION; VIET NAM; COHORT ANALYSIS; COMPLICATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; MIDDLE AGED; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; TREATMENT OUTCOME; VIROLOGY; VIRUS LOAD; YOUNG ADULT;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; DRUG USERS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME; VIETNAM; VIRAL LOAD; YOUNG ADULT;

EID: 84905643154     PISSN: 09564624     EISSN: 17581052     Source Type: Journal    
DOI: 10.1177/0956462413516301     Document Type: Article

References (34)

1. Vietnam Administration of HIV/AIDS Control: Chapter V Results. In Vietnam HIV/AIDS Estimates and Projections 2007-2012. Hanoi, Vietnam: Ministry of Health; 2009, pp.66-69, http://www.ilo.org/wcmsp5/groups/public/---ed_protect/---protrav/---ilo_aids/documents/legaldocument/wcms_174609.pdf (2012>http://www.ilo.org/wcmsp5/groups/public/---ed_protect/---protrav/---ilo_aids/documents/legaldocument/wcms_174609.pdf (2012, accessed 20 October 2013).
2. HIV/AIDS in the South-East Asia Region: Progress Report 2011, http://www.searo.who.int/entity/hiv/documents/hiv-aids_in_south-east_asia.pdf. (2011, accessed 20 October 2013).
3. Strathdee SA,Stockman JK.Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions.Curr HIV/AIDS Rep. 2010;7:99-106.
4. Nguyen VT,Scannapieco M.Drug abuse in Vietnam: a critical review of the literature and implications for future research.Addiction. 2008;103:535-543.
5. Mathers BM,Degenhardt L,Phillips Bet al.Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review.Lancet. 2008;372:1733-1745.
6. Guidelines for HIV care and treatment, Hanoi Vietnam, 2009, http://www.ilo.org/wcmsp5/groups/public/Mathers BMed_protect/Degenhardt Lprotrav/Phillips Bilo_aids/documents/legaldocument/wcms_177880.pdf>http://www.ilo.org/wcmsp5/groups/public/et al.ed_protect/---protrav/---ilo_aids/documents/legaldocument/wcms_177880.pdf (2009, accessed 20 October 2013).
7. WHO/UNAIDS progress report, 2011 http://whqlibdoc.who.int/publications/2011/9789241502986_eng.pdf (2011, accessed 20 October 2013).
8. Oyugi JH,Byakiki-Tusiime J,Ragland Ket al.Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed does combination antiretroviral therapy in Kampala, Uganda.AIDS. 2007;21:965-967.
9. Bangsberg DR,Kroetz DL,Deeks SG.Adherence-resistance relationships to combination HIV antiretroviral therapy.Curr HIV/AIDS Rep. 2007;4:65-72.
10. Lewis MP,Colbert A,Erlen Jet al.A qualitative study of persons who are 100% adherent to antiretroviral therapy.AIDS Care. 2006;18:140-148.
11. Jordan MR,La H,Nguyen HDet al.Correlates of HIV-1 viral suppression in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam.Int J STD AIDS. 2009;20:418-422.
12. Chander G,Lau B,Moore RD.Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection.J Acquir Immune Defic Syndr. 2006;43:411-417.
13. Arnsten JH,Demas PA,Grant RWet al.Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.J Gen Intern Med. 2002;17:377-381.
14. Jaquet A,Ekouevi DK,Bashi Jet al.Alcohol use and non-adherence to antiretroviral therapy in HIV-infected patients in West Africa.Addiction. 2010;105:1416-1421.
15. Do HM,Dunne MP,Kato Met al.Factors associated with suboptimal adherence to antiretroviral therapy in Viet Nam: a cross-sectional study using computer-assisted self-interview (ACASI).BMC Infect Dis. 2013;13:154.
16. Tran B,Nguyen L,Nguyen Net al.Determinants of antiretroviral treatment adherence among HIV/ AIDS patients: a multisite study.Global Health Action. 2013;6:.
17. Lu M,Safren SA,Skolnik et al.Optimal recall period and response task for self-reported HIV medication adherence.AIDS Behav. 2008;12:86-94.
18. Feldman BJ,Fredericksen RJ,Crane PKet al.Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV.AIDS Behav. 2013;17:307-318.
19. Berg KM,Wilson IB,Li Xet al.Comparison among antiretroviral adherence questions.AIDS Behav. 2012;16:461-468.
20. Vietnamese Ministry of Health. Guidelines for diagnosis and treatment of HIV/AIDS, http://iycn.wpengine.netdna-cdn.com/files/Vietnam-National-Guidelines-and-Procedure-of-Care.pdf>http://iycn.wpengine.netdna-cdn.com/files/Vietnam-National-Guidelines-and-Procedure-of-Care.pdf (2005, accessed 20 October, 2013).
21. The physician's guide to helping patients with alcohol problems. Washington DC: National Institutes of Health; 1995:.
22. Miettinen OSTheoretical epidemiology: principles of occurrence research in medicine. New York: Wiley; 1985:.
23. Westergaard RP,Hess T,Astemborski Jet al.Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users.AIDS. 2013;27:2559-2566.
24. Magura S,Siddiqi Q,Freeman RCet al.Changes in cocaine use after entry to methadone treatment.J Addict Dis. 1991;10:31-45.
25. Tran BX,Ohinmaa A,Duong AT.Changes in drug use are associated with health-related quality of life improvements among methadone maintenance patients with HIV/AIDS.Qual Life Res. 2012;21:613-623.
26. Nguyen TTM,Nguyen LT,Pham MDet al.Methadone maintenance therapy in Vietnam: an overview and scaling up plan.Adv Prevent Med. 2012;:.
27. Tran BX,Ohinmaa A,Mills Set al.Multilevel predictors of concurrent opioid use during methadone maintenance treatment among drug users with HIV/AIDS.PLoS One. 2012;7:e51569.
28. Wasti SP,Simkhada P,Randall Jet al.Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study.PLoS One. 2012;7:e35547.
29. Cescon AM,Cooper C,Chan Ket al.Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort.HIV Med. 2011;12:352-360.
30. Maqutu D,Zewotir T,North Det al.Determinants of optimal adherence over time to antiretroviral therapy amongst HIV positive adults in South Africa: a longitudinal study.AIDS Behav. 2011;15:1465-1474.
31. Wakibi S,Ng'ang'a ZW,Mbugua GG.Factors associated with non-adherence to highly active antiretroviral therapy in Nairobi, Kenya.AIDS Res Ther. 2011;8:43.
32. Tran BX,Houston S.Mobile phone-based antiretroviral adherence support in Vietnam: feasibility, patient's preference, and willingness-to-pay.AIDS Behav. 2012;16:1988-1992.
33. McMahon JH,Jordan MR,Kelley Ket al.Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring.Clin Infect Dis. 2011;52:493-506.
34. Hong SY,Jerger L,Jonas Aet al.Medication possession ratio associated with short-term virologic response in individuals initiating antiretroviral therapy in Namibia.PLoS One. 2013;8:e56307.